These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29126876)

  • 1. "Melanie's measles" is deadly and causes permanent neurologic impairment.
    Hotez PJ
    Microbes Infect; 2018 Feb; 20(2):63-64. PubMed ID: 29126876
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measles vaccination].
    Gendrel D
    Presse Med; 1993 Sep; 22(28):1299-301. PubMed ID: 8248054
    [No Abstract]   [Full Text] [Related]  

  • 4. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health impact of measles vaccination in the United States.
    Bloch AB; Orenstein WA; Stetler HC; Wassilak SG; Amler RW; Bart KJ; Kirby CD; Hinman AR
    Pediatrics; 1985 Oct; 76(4):524-32. PubMed ID: 3931045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan, 1970-1996].
    Hirayasu K; Nakada Y; Takaesu E; Kamiya K; Hirayama K
    No To Hattatsu; 1999 Jan; 31(1):27-31. PubMed ID: 10025131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reasons for vaccinating against measles].
    Celers J; Netter R
    Bull Acad Natl Med; 1982 Jun; 166(6):801-7. PubMed ID: 6756595
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan--the second report 1977-1999].
    Hirayasu K; Nakada Y; Oshiro S; Takaesu E; Nakamura K; Shiroma N; Minema H
    No To Hattatsu; 2004 Jan; 36(1):21-5. PubMed ID: 14737859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis in the developing world.
    Moodley M
    S Afr Med J; 1992 Aug; 82(2):72-4. PubMed ID: 1509330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska-Buksowicz B; Kulczycki J
    Neurol Neurochir Pol; 1999; 33(3):653-63. PubMed ID: 10540725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subacute sclerosing panencephalitis in The Netherlands (1976-1986)].
    Beersma MF; Kapsenberg JG; Renier WO; Galama JM; van Druten JA; Lucas CJ
    Ned Tijdschr Geneeskd; 1988 Jun; 132(26):1194-9. PubMed ID: 3398949
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles in the RSA.
    Moodie JW
    S Afr Med J; 1986 Oct; Suppl():57-60. PubMed ID: 3775561
    [No Abstract]   [Full Text] [Related]  

  • 16. Current impact of measles in the United Kingdom.
    Miller CL
    Rev Infect Dis; 1983; 5(3):427-32. PubMed ID: 6878994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of measles in France.
    Rey M; Celers J; Mouton Y; Netter R
    Rev Infect Dis; 1983; 5(3):433-8. PubMed ID: 6878995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological, neuropathological, clinico-evolutive and EEG aspects of immunologically confirmed measles of subacute sclerosing panencephalitis].
    Milea S; Stefan M; Cantili L; Roman I; Osiescu J; Cernescu C; Măgureanu S; Oancea C; Alexianu M; Dan A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(1):45-59. PubMed ID: 6232694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Encephalitic complications of measles in 1987].
    Celers J; Netter R
    Bull Acad Natl Med; 1989 Feb; 173(2):133-8; discussion 139. PubMed ID: 2765992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.